General Information
Revision date
2019-07-01
Product name
Ruxolitinib, Phosphate Salt
CAS No.
1092939-17-7
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
Harmful Harmful if swallowed May be harmful if inhaled or through skin absorption Ingestion may result in thrombocytopenia (reduced blood platelets), neutropenia (reduction of a certain type of white blood cells), anemia, bruising/unusual bleeding, dizziness, headache, fatigue, dyspnea (shortness of breath), infection involving chills, aches, fever, nausea, vomiting, weakness, painful skin rash or blisters Prolonged exposure may result in serious damage to health Exposure may adversely affect fetal development and may impair fertility May be irritating to skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
